当前位置:首页 - 行情中心 - 恩华药业(002262) - 财务分析 - 现金流量表

恩华药业

(002262)

  

流通市值:196.82亿  总市值:226.81亿
流通股本:8.82亿   总股本:10.16亿

现金流量表

报告期2024-12-312024-09-302024-06-302024-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金5,938,902,382.234,460,686,320.822,887,392,946.681,437,966,302.56
收到的税费返还253,387.85101,940.556,262.0119,865.69
收到其他与经营活动有关的现金75,608,438.6387,885,842.3560,788,640.8328,414,596.46
经营活动现金流入的平衡项目0000
经营活动现金流入小计6,014,764,208.714,548,674,103.672,948,237,849.521,466,400,764.71
购买商品、接受劳务支付的现金1,290,808,305.731,056,922,175.31621,534,383.16343,920,750.51
支付给职工以及为职工支付的现金994,451,862.99765,397,870.11451,398,023.32222,224,489.29
支付的各项税费738,389,529.24554,690,316.92397,272,732.16208,319,468.23
支付其他与经营活动有关的现金2,074,988,007.691,260,471,047.77856,195,632.22458,353,781.38
经营活动现金流出的平衡项目0000
经营活动现金流出小计5,098,637,705.653,637,481,410.112,326,400,770.861,232,818,489.41
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额916,126,503.06911,192,693.56621,837,078.66233,582,275.3
二、投资活动产生的现金流量:
取得投资收益收到的现金46,119,276.8337,366,622.9417,421,656.016,725,654.77
处置固定资产、无形资产和其他长期资产收回的现金净额799,445.43603,821143,711-
收到的其他与投资活动有关的现金6,201,010,0004,687,010,0002,468,000,0001,005,000,000
投资活动现金流入的平衡项目0000
投资活动现金流入小计6,247,928,722.264,724,980,443.942,485,565,367.011,011,725,654.77
购建固定资产、无形资产和其他长期资产支付的现金450,055,947.44279,616,120.6209,637,331.564,247,521.29
取得子公司及其他营业单位支付的现金340,400---
支付其他与投资活动有关的现金7,209,010,0005,652,010,0003,225,010,0001,621,000,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计7,659,406,347.445,931,626,120.63,434,647,331.51,685,247,521.29
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,411,477,625.18-1,206,645,676.66-949,081,964.49-673,521,866.52
三、筹资活动产生的现金流量:
吸收投资收到的现金98,855,93798,855,937--
取得借款收到的现金65,000,00064,677,448.3749,758,172.2320,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计163,855,937163,533,385.3749,758,172.2320,000,000
偿还债务支付的现金105,000,00055,067,00020,067,00010,000,000
分配股利、利润或偿付利息支付的现金323,774,577.78324,226,576.71324,939,877.81,280,498.22
支付其他与筹资活动有关的现金36,051,872.0749,937,717.6514,540,258.196,768,506.6
筹资活动现金流出平衡项目0000
筹资活动现金流出小计464,826,449.85429,231,294.36359,547,135.9918,049,004.82
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-300,970,512.85-265,697,908.99-309,788,963.761,950,995.18
四、汇率变动对现金及现金等价物的影响171,089.65213,136.17177,182.17129,752.08
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-796,150,545.32-560,937,755.92-636,856,667.42-437,858,843.96
加:期初现金及现金等价物余额2,009,612,825.292,009,612,825.292,009,612,825.292,009,612,825.29
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,213,462,279.971,448,675,069.371,372,756,157.871,571,753,981.33
补充资料:
净利润1,140,792,302.84-626,573,552.5-
资产减值准备73,644,009.77-23,246,579.14-
固定资产和投资性房地产折旧132,277,340.56-65,270,028.06-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧132,277,340.56-65,270,028.06-
无形资产摊销19,157,803.46-8,387,854.65-
长期待摊费用摊销52,187,688.57-23,224,040.34-
处置固定资产、无形资产和其他长期资产的损失-293,968.27--28,993.71-
固定资产报废损失-68,993.34--927,819.63-
财务费用3,854,788.55-2,165,148.89-
投资损失-65,568,560.11--20,851,926.82-
递延所得税1,585,817.52-8,279,482.29-
其中:递延所得税资产减少2,935,866.1-9,740,551.28-
递延所得税负债增加-1,350,048.58--1,461,068.99-
存货的减少-71,797,464.89-89,716,707.24-
经营性应收项目的减少-512,980,906.9--306,603,083.27-
经营性应付项目的增加81,709,654.68-90,514,359.75-
其他31,051,725.7---
现金的期末余额1,213,462,279.97-1,372,756,157.87-
减:现金的期初余额2,009,612,825.29-2,009,612,825.29-
公告日期2025-03-292024-10-262024-07-312024-04-20
审计意见(境内)标准无保留意见
TOP↑